Medical Device CRO

Monitoring
Auditing
Training
Consulting

Home
Our Team
Services
Careers
About
Resources
Contact
Blog

Subscribe via E-mail

Your email:

Most Recent

How Would You Improve FDA’s Device Review Process?
From Review to Application: Good Clinical Practice
IMARC’s December e-Newsletter
Could Industry Sponsored Clinical Trials be Biased?
3 Steps FDA’s Taken for Home Use of Medical Devices
Running a Clinical Trial Outside the US? Be Prepared.
“If it is Not Documented, It Was Not Done”
Case Study: Medical Device FDA Inspection
5 Questions Regarding the Medical Device Tax
How to Tackle Complicated Clinical Trials

Browse by Category

2.3% Medical Device (1)
2012 Medival Innovation Summit (1)
2013 (1)
2013 To-Do List (1)
21 CFR § 50.25(c) (1)
21 CFR 312 (1)
21 CFR 50.20 (1)
21 CFR 54 (1)
21 CFR 56 (2)
21 CFR 56.113 (1)
21 CFR 812 (2)
21 CFR 812.110 (1)
21 CFR 812.140 (2)
21 CFR 812.140(a) (1)
21 CFR Part 56 (2)
45 CFR 46 (1)
510(k) (16)
510(k) Loophole (1)
510(k) NSE Determination (1)
510(k) Program (1)
A Call for Change (1)
Acronyms (1)
ACRP (1)
AdvaMed (4)
Affordable Care Act (2)
ALCOA (2)
Alexey Bersenev (1)
Amy Siegel (1)
and Cosmetic Act of 1938 (1)
Assent (1)
Audit (1)
Auditing Services (1)
AxioMed (1)
Benefit-Risk Determination (1)
BIMO (1)
BioEnterprise (2)
Bioscience (1)
brandy smith (1)
CAPA (1)
Cardinal Health (1)
Carl Heneghan (1)
Carmen R. Gonzales (1)
CDRH (3)
Cell Therapy (1)
cell therapy products (1)
Cell Therapy Trials (1)
Center for Devices and Radiological Health (1)
Centralized Monitoring (1)
CFR Part 50 (1)
Charlie Chie (1)
Checklist (1)
Children in Clinical Research (1)
Choosing a CRO (1)
Cleveland (1)
Cleveland Clinic (1)
Clinica Research (1)
Clinical Communications (1)
Clinical Data (2)
Clinical Data Requirements (1)
Clinical Drug Data (1)
Clinical Investigator (1)
Clinical Research (18)
Clinical Research Coordinator (2)
Clinical Research Organization (1)
Clinical Research Trials (1)
Clinical Studies (3)
Clinical Subjects (1)
Clinical Trial (2)
Clinical Trial Documentation (1)
Clinical Trial Endpoints (1)
Clinical Trial Enrollment (1)
Clinical Trial Imaging (1)
Clinical Trial Loophole (1)
Clinical Trial Monitoring (1)
Clinical Trial Volunteer (1)
Clinical Trials (13)
ClinPage (1)
Cochrane Group (1)
Code of Federal Regulations (2)
combination products (1)
compliance (2)
Complicated Clinical Trials (1)
Concerns (1)
Conflict of Interest (2)
Congressmen Edward Markey (1)
Content Management (1)
Cook Medical (1)
Coordinators (1)
Corrective Actions (1)
Corrective and Preventive Actions (1)
Corruption (1)
Cost-Savings (1)
CRA Retention (1)
CRO (3)
Dateline (1)
de novo classification (1)
De Novo Process (1)
Debate (1)
Declaration of Helsinki (1)
De-identification (1)
Derycz Scientific (1)
Device Accountability (1)
Device Classification (1)
Device Compliance (1)
Device Quality (1)
Device Recall Reports (1)
Device Review (1)
Device Review Process (1)
Device Reviews (1)
Direct Communication (1)
D-Mass (1)
Document Your Work (1)
Documentation in Clinical Research (1)
Documentation in Device Studies (1)
Dr. Andrew von Eschenbach (1)
Dr. Andrew von Eschenback (1)
Dr. Harvey Arbit (1)
Draft Guidance (2)
Drug (1)
Drugs versus Devices (1)
Ed Markey (1)
Edgewood Arsenal Experiments (1)
Electronic Regulatory Compliance (1)
Electronic Source Data (1)
EMA (1)
Emerging Markets (1)
Emergo Group (1)
eNewsletter (2)
EU (1)
EU Regulatory System (1)
European Medicines Agency (EMA) (1)
FAIR Shake (1)
FAIR Shake technique (1)
FAIR Shake Training Technique (1)
FAIR Shake™ Training Method (1)
Faster FDA Device Approvals (1)
FD&C; Act (1)
FDA (86)
FDA Audit (1)
FDA Audit Responses (1)
FDA BIMO inspection (1)
FDA Draft Guidance (1)
FDA Enforcement Reports (1)
FDA Guidance (3)
FDA Inspection (1)
FDA Safety and Innovation Act (1)
FDA Security Plan (1)
FDA Warning Letters (3)
FDA Website (1)
FDA's Center for Devices and Radiological Heal (1)
Federal Register (4)
Federal Regulations (2)
Financial Disclosure (1)
Foreign Corruption Practices Act (1)
Form 483 (1)
Former Pre-IDE Program (1)
From Review to Application (1)
Fuld & Company (1)
GCP/Regulatory Training (1)
Gene Therapy (1)
Global Clinical Trials (1)
Global Harminzation Task Force (1)
Global Priority (1)
Going Green (1)
Gold Medal (1)
Good Clinical Practice (7)
Good Documentation Practices (1)
Good Monintor (1)
Greg Bonfiglio (1)
Greg Davis (1)
Growth Opportunity (1)
Guidance Documents (1)
Healing Innovations (1)
Health Wellness (1)
Healthcare Startups (1)
HHS (1)
High-Risk Devices (1)
HIPAA (2)
Home Use of Medical Devices (1)
House of Representatives (1)
Human Subject Protection (1)
humanitarian device exemption (1)
Hurricane Sandy (1)
ICH GCP (1)
ICH GCP E6 4.8.3 (1)
ImageIQ (2)
Imaging in Clinical Trials (1)
IMARC Research (7)
IMARC Research Whitepaper (3)
IMARC Whitepaper (1)
Impact Profits (1)
Implantable Devices (1)
Improper Consent (1)
Improve Site Compliance (1)
Industry Sponsored Clinical Trials (1)
Infographic (2)
Informed Consent (7)
Informed Consent Process (1)
Innovation (1)
Innovation Pathway 2.0 (1)
Institute of Medicine (1)
Integrated EDC/EHR System (1)
International Organization for Standardization (1)
Investigator Oversight (1)
IRB (6)
IRB Oversight (2)
IRB Reporting Compliance (1)
Is Your Trial Complex (1)
JD (1)
Joe Hage (1)
john lehmann (14)
Journal of Clinical Research Best Practices (1)
Kem Hawins (1)
Ketek Trial (1)
Kips Bay Medical (1)
life science (1)
LinkedIn (1)
LinkedIn Group (1)
Literacy (1)
Margaret Hamburg (3)
MassDevice (2)
md+di (7)
MDUFA (1)
Med Tech Companies (1)
MedCelerate (1)
MedCity News (2)
MedCityNews (1)
Medical Device (18)
Medical Device Clinical Trial (1)
Medical Device Companies (4)
Medical Device CRO (4)
Medical Device Development (1)
Medical Device Firms (1)
Medical Device Generics (1)
Medical Device Industry (5)
Medical Device Maker; Post-Market Studies (1)
Medical Device Manufacturers (1)
Medical Device Market (1)
Medical Device Oversight (1)
Medical Device Patient Safety Act (1)
medical device patients (1)
Medical Device Professionals (1)
Medical Device Recalls (1)
Medical Device Review Guidelines (1)
Medical Device Submissions (1)
Medical Device Tax (6)
Medical Device User Fee & Modernization Act (1)
Medical Device User Fee Act (1)
Medical Device Users Fees (1)
Medical Devices (4)
Medical Devices Group (1)
MedTech (1)
Med-tech (1)
MedTech Doom and Gloom (1)
Medtech Industry (1)
Med-Tech Industry Acronyms (1)
MedTech Job Growth (1)
Merrill Goozner (1)
Michael Santalucia (1)
Modernize Clinical Trials (1)
Monitor (4)
Monitoring (3)
Monitors (4)
Muscular Dystrophy Association (1)
National Database (1)
New England Journal of Medicine (2)
New FDA Draft Guidance (1)
New FDA Guidance (2)
New Symptom (1)
New York Times (1)
nick woods (1)
Non-English Speaking Subjects (1)
Non-Signficant Risk (1)
notes-to-file (1)
Nuremberg Code (1)
office of combination products (1)
Office of Device Evaluation (1)
Office of Information and Regulatory Affairs (1)
Ohio (2)
OMTEC 2012 Conference (1)
Onsite Monitoring (1)
ORTHOWORLD (2)
Outsourcing (1)
Outsurcing IRBs (1)
Overseas Clinical Trials (1)
Pathway to Global Product Safety and Quality (1)
Patient Protection and Affordable Care Act (1)
Patients (1)
PhD (1)
Plain Writing Act for Regulations of 2012 (1)
PMA (1)
Postmarket Surveillance Plan (1)
Postmarketing Surveillance System (1)
Preclinical Communications Strategies (1)
Pre-IDE Meeting (1)
Premarket Approval Application (2)
Premarket Approval Applications (1)
Pre-Submission Program (1)
PricewaterhouseCoopers (1)
Principal Investigator Oversight (2)
Pros and Cons (1)
Protection of Human Subjects (1)
Protocol Waiver (1)
Public Citizens (1)
Quality in Device Trials (1)
RAPS (1)
Reason Patients Withdraw (1)
Recruitment (2)
Refuse to Accept Policy (1)
Refuse to Accept Policy for 510(k)s (1)
Regulation Renovation (1)
Regulation Revelations (1)
Regulations (5)
Regulatory Binder (1)
Regulatory Environment in Europe (1)
Regulatory Reform Act of 2012 (1)
Regulatory Science (1)
Regulatory Strategy (1)
Regulatory System (1)
Relationship (1)
Rep. Edward Markey (1)
Research Coordinator (1)
Research Industry (1)
Research Professionals (1)
Research Volunteer (1)
REU Associates (1)
Review/Approval Time-Lines (1)
Right Balance (1)
Risk Analysis (1)
Risk-Based Approach to Monitoring (1)
Risk-based Monintoring (1)
Risk-Based Monitoring (1)
Safety and Effectiveness (1)
Safety and Efficacy (1)
Sandra Maddock (5)
Save Money (1)
Sen. Jeff Merkley (1)
Senators (1)
Sentinel Assurance of Effective Devices of 2012 (1)
SET Device Act (1)
Shorten Time to Market (1)
Shortened Informed Consent Form (1)
Signficant Risk (1)
Site Compliance (1)
Site Enrollment (1)
social media (2)
Source Documents (1)
Sponsor (2)
Sponsor-Investigator (1)
sponsor-investigators (1)
Standard Operating Procedures (1)
Standardizing Data Submission (1)
Steve Silverman (1)
Stone Carlie Blog (1)
Strategic Top Priorities (1)
Study Coordinator (1)
Study Evidence (1)
Subject (1)
Subject Protection (1)
Sunshine Act (1)
technology solutions (2)
Texting (1)
The 2012 Ohio Bioscience Growth Report (1)
The Affordable Care Act (1)
The Biotechnology Industry Organization (1)
The Checklist Manifesto (1)
The FDA Reform Act (1)
The Food (1)
The Jobs Act (1)
The Medical Device User Fee Act Reauthorization (1)
The Medtech Resource Alliance (1)
The Nocebo Effect (1)
Threats to Medical Device Industry (1)
To-Do List (2)
Top 10 Medical Innovations (1)
Top 10 Tips (1)
Top 3 Challenges (1)
Top 5 (1)
Top Five Trial Compliations (1)
Trial and Experimental Studies Transparency Act of (1)
Tufts Center for Study of Drug Development (1)
Tuskegee Syphilis Study (1)
U.S. Military (1)
UDI (1)
UDI Provisions (1)
UDI Rule (1)
Understandable Language (1)
Union of Concerned Scientist (1)
Unique Device Identification (1)
United States (1)
US Government Accountability Office (1)
US Regulatory System (1)
User Deal (1)
Voluntary Audits (1)
Wall Street (1)
Warning Letter (1)
Warning Letters (4)
Well-Controlled Clinical Study (1)
Whitepaper (1)
World Health Organization (1)
World Medical Association (1)

Medical Device CRO Blog

Current Articles | RSS Feed

FDA’s To-Do List 2013 - PART I

Posted by John Lehmann on Mon, Nov 26, 2012 @ 07:15 AM

The CDRH (Center for Devices and Radiological Health) recently released their annual proposed Guidance development document for the upcoming fiscal year. This provides an overview of the intended guidance documents FDA plans to fully publish, and those documents FDA hopes to publish.

0 Comments Click here to read/write comments